< Back to companies
Carelane

Carelane

Berlin, Germany

Carelane is an AI-driven clinical research platform designed to accelerate Phase I-IV trials, registries, and other clinical studies. It unifies critical components such as EDC (Electronic Data Capture), ePRO (electronic Patient-Reported Outcomes), Consent Management, CTMS (Clinical Trial Management System), and more into a single, high-speed infrastructure. By operating on a single source of truth, Carelane eliminates manual friction, reducing study timelines by up to 70% and costs by up to 80%. The platform supports end-to-end trial execution, including protocol development, data management, and automation, and is the only end-to-end solution tailored specifically for observational trials.

Share
Shareable draft
Get Involved in Carelane

Company Info

Founded
2023
Website
www.carelane.io
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Carelane?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Carelane
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free